Parotid salivary duct carcinoma: a single institution’s 20-year experience
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Otorhinolaryngology
Link
http://link.springer.com/content/pdf/10.1007/s00405-019-05454-0.pdf
Reference17 articles.
1. Kleinsasser O, Klein HJ, Hubner G (1968) Salivary duct carcinoma: a group of salivary gland tumours analogous to mammary duct carcinoma. Arch Klin Exp Ohren Nasen 192:100–105
2. Skálová A, Stárek I, Kucerová V, Szépe P, Plank L (2001) Salivary duct carcinoma–a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression. Pathol Res Pract 197:621–626
3. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) (2017) WHO classification of head and neck tumours, 4th edn. IARC, Lyon
4. Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL Jr, Rigual NR, Sullivan MA, Seshadri M, Marshall JR, Cohan DM, Zhao Y, Singh AK (2014) Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the surveillance, epidemiology, and end results database. Head Neck 36:694–701
5. Schmitt NC, Kang H, Sharma A (2017) Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy. Oral Oncol 74:40–48
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center;European Archives of Oto-Rhino-Laryngology;2024-04-08
2. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness;Oral Oncology;2024-04
3. Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers;Cancers;2024-03-19
4. Survival analysis of high-grade salivary gland carcinoma adjusted for length bias due to delay in comprehensive genomic profiling;Japanese Journal of Clinical Oncology;2023-09-30
5. Prognostic models for estimating survival of salivary duct carcinoma: a population-based study;European Archives of Oto-Rhino-Laryngology;2022-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3